BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28819535)

  • 1. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
    Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
    Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: A single-center retrospective study.
    Kosałka-Węgiel J; Dziedzic R; Siwiec-Koźlik A; Spałkowska M; Milewski M; Żuk-Kuwik J; Zaręba L; Bazan-Socha S; Korkosz M
    Rheumatol Int; 2024 Jul; 44(7):1283-1294. PubMed ID: 38546745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Al-Mughales JA
    Front Immunol; 2022; 13():850759. PubMed ID: 35359932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences.
    Adwan MH; Qasem U; Atawnah SY; Itmeizeh M; Hanbali R; Alsoofi NA; Jbara MA; AbuHelal A; Alnaimat F
    Rheumatol Int; 2024 Jul; 44(7):1255-1263. PubMed ID: 38717538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients.
    Tekeoglu S; Temiz Karadag D; Ozdemir Isik O; Yazici A; Cefle A
    Lupus; 2024 Mar; 33(3):298-311. PubMed ID: 38258530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis.
    Asanuma Y; Nozawa K; Matsushita M; Kusaoi M; Abe Y; Yamaji K; Tamura N
    Mod Rheumatol; 2023 Nov; 33(6):1110-1116. PubMed ID: 36469011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
    Allen PC; Roberts K; Rubio JE; Tiwari HK; Absher DM; Cooper SJ; Myers RM; Brown EE
    J Autoimmun; 2023 Sep; 139():103089. PubMed ID: 37506491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study.
    Alduraibi FK; Sullivan KA; Chatham WW; Hsu HC; Mountz JD
    Clin Immunol; 2023 Feb; 247():109239. PubMed ID: 36682593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus.
    Hartl J; Serpas L; Wang Y; Rashidfarrokhi A; Perez OA; Sally B; Sisirak V; Soni C; Khodadadi-Jamayran A; Tsirigos A; Caiello I; Bracaglia C; Volpi S; Ghiggeri GM; Chida AS; Sanz I; Kim MY; Belmont HM; Silverman GJ; Clancy RM; Izmirly PM; Buyon JP; Reizis B
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33783474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus.
    Hedenstedt A; Reid S; Sayadi A; Eloranta ML; Skoglund E; Bolin K; Frodlund M; Lerang K; Jönsen A; Rantapää-Dahlqvist S; Bengtsson AA; Rudin A; Molberg Ø; Sjöwall C; Sandling JK; Leonard D
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37844960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANA-negative severe lupus-like presentation: Is it lupus or not?
    Li S; Bian Q
    Clin Case Rep; 2023 Nov; 11(11):e8145. PubMed ID: 37965182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Immunological Profile of Systemic Lupus Erythematosus: A 5-year Retrospective Analysis from Northeast India.
    Barman B; Lyngdoh WV; Bhattarcharya PK; Lanong S; Lyngdoh M; Jamil M; Tiewsoh I; Nune A
    J Assoc Physicians India; 2024 Mar; 72(3):32-35. PubMed ID: 38736114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort.
    Chen YJ; Hsiao TH; Lin YC; Jeng WJ; Mao CL; Wei CY; Hsieh YC; Huang CJ; Pan MH; Chen IC; Lin CH; Chen YM; Yang HI
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38637112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Choi MY; Clarke AE; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg D; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Costenbader KH; Fritzler MJ
    Ann Rheum Dis; 2022 Aug; 81(8):1143-1150. PubMed ID: 35338033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.
    Frodlund M; Dahlström O; Kastbom A; Skogh T; Sjöwall C
    BMJ Open; 2013 Oct; 3(10):e003608. PubMed ID: 24163206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal.
    Azzouz D; Omarbekova A; Heguy A; Schwudke D; Gisch N; Rovin BH; Caricchio R; Buyon JP; Alekseyenko AV; Silverman GJ
    Ann Rheum Dis; 2019 Jul; 78(7):947-956. PubMed ID: 30782585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying and diagnosing systemic lupus erythematosus in the 21st century.
    Aringer M; Johnson SR
    Rheumatology (Oxford); 2020 Dec; 59(Suppl5):v4-v11. PubMed ID: 33280013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patients.
    Piranavan P; Perl A
    Clin Immunol; 2021 Aug; 229():108781. PubMed ID: 34144197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibody-associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
    Granel J; Fernandes H; Bader-Meunier B; Guth A; Richer O; Pillet P; Leverger G; Ducassou S; Fahd M; Pasquet M; Garnier N; Barlogis V; Guitton C; Jeziorski E; Thomas C; Bayart S; Cheikh N; Paillard C; Abou Chahla W; Chastagner P; Neven B; Millot F; Lejeune J; Li-Thiao Te V; Armari-Alla C; Briandet C; Carausu L; Deparis M; Piguet C; Benadiba J; Marie-Cardine A; Stephan JL; Pellier I; Pluchart C; Doré E; Michaux K; Héritier S; Leblanc T; Aladjidi N
    Blood; 2024 Apr; 143(16):1576-1585. PubMed ID: 38227934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.